OraSure appoints Nancy Gagliano as Interim CEO effective April 1, 2022; Stephen Tang terminated

ORASURE TECHNOLOGIES INC

Dr. Gagliano, a current director, becomes Interim CEO after Stephen Tang's termination as CEO and director on March 31, 2022.
Compensation includes monthly base salary of $55,833, $100k fully vested stock grant, and $670k RSU award vesting monthly over 12 months.
Board size reduced from 10 to 9 members effective April 1, 2022.
Dr. Gagliano will not participate in annual incentive or long-term incentive plans; non-employee director fees cease during tenure.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Nancy J. Gagliano

Interim Chief Executive Officer

OSUR · ORASURE TECHNOLOGIES INC

Effective: 2022-04-01
Filed: March 23, 2022, 7:59 PM ET

appointed Nancy J. Gagliano, M.D., M.B.A., a current director of the Company, to serve as the Company’s Interim Chief Executive Officer

Departed

Stephen S. Tang

President and Chief Executive Officer

OSUR · ORASURE TECHNOLOGIES INC

Effective: 2022-03-31
Successor: Nancy J. Gagliano
Filed: March 23, 2022, 7:59 PM ET

following the termination of Stephen S. Tang as a director and the Company’s President and Chief Executive Officer on March 31, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nancy J. Gagliano was appointed as Interim Chief Executive Officer at ORASURE TECHNOLOGIES INC.

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

appointed Nancy J. Gagliano, M.D., M.B.A., a current director of the Company, to serve as the Company’s Interim Chief Executive Officer

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen S. Tang was terminated as President and Chief Executive Officer at ORASURE TECHNOLOGIES INC.

Action: terminated
Role: President and Chief Executive Officer

Exact text from the filing

following the termination of Stephen S. Tang as a director and the Company’s President and Chief Executive Officer on March 31, 2022

View on SEC.gov

ORASURE TECHNOLOGIES INC filing history →

Source: SEC EDGAR

accession 0001193125-22-082900

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.